Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
Author:
Publisher
John Wiley & Sons, Ltd
Link
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006650.pub2/epdf/full
Reference73 articles.
1. Three-month, outpatient, oral anticoagulant treatment in comparison with low-molecular-weight heparin in cancer patients;Cesarone,2003
2. Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period;Deitcher;Clinical & Applied Thrombosis/Hemostasis,2006
3. Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer;Hull;The American Journal of Medicine,2006
4. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer;Lee;The New England Journal of Medicine,2003
5. Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis;Lopez-Beret;Journal of Vascular Surgery,2001
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018;Journal of the National Comprehensive Cancer Network;2018-11
2. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer;Cochrane Database of Systematic Reviews;2018-06-19
3. Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial;Drug Safety;2015-11-07
4. Impact of cancer on the effectiveness of cardiac Troponin I to predict right ventricular dysfunction in acute pulmonary embolism;Thoracic Cancer;2015-01-22
5. Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes;PLoS ONE;2014-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3